Monterey Bio Acquisition Corporation (MTRYW) ist ein börsennotiertes Unternehmen im Finanzdienstleistungen Sektor, tätig in der Shell Companies Branche. Der Hauptsitz des Unternehmens ist in New York City, NY, United States. Der aktuelle CEO ist Sanjeev Satyal.
MTRYW hat IPO-Datum 2021-11-22, gelistet an der NASDAQ Global Market, eine Marktkapitalisierung von $48.3M.
Monterey Bio Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to acquire businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.
